Literature DB >> 3907120

Transcriptive complex of Newcastle disease virus. II. Structural and functional assembly associated with the cytoskeletal framework.

M Hamaguchi, K Nishikawa, T Toyoda, T Yoshida, T Hanaichi, Y Nagai.   

Abstract

The transcriptive complex, the nucleocapsid with the viral RNA-synthesizing activity, of Newcastle disease virus (NDV) contains three protein components, the major structural subunit (NP) and two associated proteins (P and L) involved in the RNA synthesis. We studied the pathway of these proteins from synthesis to assembly into the complex by pulse-chase labeling of infected cells followed by detergent extraction of the cells to separate soluble and cytoskeletal fractions. Most molecules of NP and P (and probably L) became associated with the cytoskeletal framework immediately after their synthesis. Most of the remaining molecules were initially found in the soluble fraction, but joined the cytoskeletal framework within several minutes. Once attached, none of the proteins left the cytoskeleton, and it was here that they assembled with 50 S viral RNA into nucleocapsids. The nucleocapsids thus formed remained bound to the cytoskeletal framework and were found by in situ autoradiography to exhibit viral RNA synthesis on the framework. These results suggested that the cytoskeletal framework could actively participate in the structural and functional assembly of NDV transcriptive complex.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3907120     DOI: 10.1016/0042-6822(85)90132-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  26 in total

1.  Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication.

Authors:  Y van der Meer; E J Snijder; J C Dobbe; S Schleich; M R Denison; W J Spaan; J K Locker
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Intranuclear inclusions in paramyxovirus-induced encephalitis: evidence for altered nuclear body differentiation.

Authors:  M Oglesbee
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Transcription of human respiratory syncytial virus genome RNA in vitro: requirement of cellular factor(s).

Authors:  S Barik
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  Rescue of a foreign gene by Sendai virus.

Authors:  K H Park; T Huang; F F Correia; M Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

5.  Karyophilic properties of Semliki Forest virus nucleocapsid protein.

Authors:  M R Michel; M Elgizoli; Y Dai; R Jakob; H Koblet; A P Arrigo
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

6.  Mutational analysis reveals a noncontractile but interactive role of actin and profilin in viral RNA-dependent RNA synthesis.

Authors:  Mary Harpen; Tiasha Barik; Alla Musiyenko; Sailen Barik
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

7.  Stimulation of vesicular stomatitis virus in vitro RNA synthesis by microtubule-associated proteins.

Authors:  V M Hill; S A Harmon; D F Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA.

Authors:  E Burke; N M Mahoney; S C Almo; S Barik
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

9.  Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor.

Authors:  Stephen W Mason; Carol Lawetz; Yvon Gaudette; Florence Dô; Erika Scouten; Lisette Lagacé; Bruno Simoneau; Michel Liuzzi
Journal:  Nucleic Acids Res       Date:  2004-09-08       Impact factor: 16.971

10.  Detection of polycistronic transcripts in Newcastle disease virus infected cells and identification of their sequence content.

Authors:  T Toyoda; M Hamaguchi; Y Nagai
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.